Sign Up to like & get
recommendations!
1
Published in 2022 at "Molecular Oncology"
DOI: 10.1002/1878-0261.13357
Abstract: Brain metastasis (BM) genetically diverges from the primary tumor in non‐small‐cell lung cancer (NSCLC). Hence, accurately capturing clinically relevant alterations is pivotal for the delivery of targeted therapies. Circulating tumor DNA (ctDNA) sequencing has emerged…
read more here.
Keywords:
ctdna;
plasma ctdna;
brain;
tumor ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz175.786
Abstract: For midline tumors, surgical biopsy risks neurological injury. Non-invasive methods for diagnosis and surveillance are greatly needed. Tumors release DNA into cerebrospinal fluid (CSF-ctDNA), allowing for potential detection and serial monitoring of tumor-associated genetic mutations…
read more here.
Keywords:
glioma;
high grade;
csf;
csf ctdna ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-1053
Abstract: Intro: High-Grade Gliomas (HGGs) are the most common and aggressive primary brain tumors in adults and are almost always fatal. Liquid biopsy provides a noninvasive window into the cancer genome and the underlying biology of…
read more here.
Keywords:
circulating tumor;
ctdna;
csf;
glioma ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of the National Comprehensive Cancer Network : JNCCN"
DOI: 10.6004/jnccn.2022.7093
Abstract: Most pediatric central nervous system (CNS) tumors are located in eloquent anatomic areas, making surgical resection and, in some cases, even biopsy risky or impossible. This diagnostic predicament coupled with the move toward molecular classification…
read more here.
Keywords:
csf ctdna;
pediatric central;
cns tumors;
ctdna ... See more keywords